Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
- Posted on September 21, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
